WALTHAM, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a…
Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of…
Rosenbaum, David P. - Vorstand - Tag der Transaktion: 2023-03-29...…
In the latest trading session, Ardelyx (ARDX) closed at $4.05, marking a +0.5% move from the previous day....…
Ardelyx Shares Rally on 4Q Update, Bullish Analyst View >ARDX...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Fridays pre-market trading (as of…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the…
Ardelyx Shares Rise 9.34% After Hours Following 4Q Results...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a…
Renz, Justin A. - Vorstand - Tag der Transaktion: 2023-02-21...…
Rosenbaum, David P. - Vorstand - Tag der Transaktion: 2023-02-21...…
Felsch, Robert Ora - Vorstand - Tag der Transaktion: 2023-02-21...…
Grammer, Elizabeth A. - Vorstand - Tag der Transaktion: 2023-02-21...…
Williams, Laura A. - Vorstand - Tag der Transaktion: 2023-02-21...…
Raab, Michael - Vorstand - Tag der Transaktion: 2023-02-21...…
Blanks, Robert - Vorstand - Tag der Transaktion: 2023-02-21...…
Ardelyx (ARDX) closed the most recent trading day at $2.95, moving +0.34% from the previous trading session....…
Ardelyx (ARDX) closed at $3.02 in the latest trading session, marking a -1.63% move from the prior day....…
In the latest trading session, Ardelyx (ARDX) closed at $3.31, marking a +0.91% move from the previous day....…
In the latest trading session, Ardelyx (ARDX) closed at $3.07, marking a +1.99% move from the previous day....…
WALTHAM, Mass., Feb. 2, 2023 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…
Ardelyx Up 16%, Rebounding From Thursday Decline...…
NEW YORK, Dec. 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMBL, ARDX, GOTU, HOTH, and IQ. To…
Ardelyx Appeal of Xphozah Denial Granted by FDA...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ardelyx Inc. ARDX stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharmaceutical company said the…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
WALTHAM, Mass., Dec. 23, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…
NEW YORK, Dec. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CORZ, DBVT, GOTU, EDU, and ARDX. To…
Futures Rise On China Growth Hopes
After US stocks…
Ardelyx Shares Lower Premarket on Delay in FDA Xphozah Appeal >ARDX...…
WALTHAM, Mass., Dec. 16, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…
Rosenbaum, David P. - Vorstand - Tag der Transaktion: 2022-11-22...…
WALTHAM, Mass., Nov. 22, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…
The FDAs CRDAC recommends granting marketing approval to Ardelyxs (ARDX) oral pill to control serum phosphorus in adult patients with…
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
In a surprise move, a committee of the agency’s outside advisors voted in favor of the proposition that the drug's…
Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an…
CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursdays pre-market trading (as of 06.40…
Ardelyx Shares Soar Premarket After FDA Panel Back Xphozah >ARDX...…
Ardelyx: FDA Committee Says Benefits of Xphozah Outweigh Risks in Kidney Disease Patients...…
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ardelyx Halted as FDA Panel Takes Another Look at Xphozah >ARDX...…
Instrument ID [7381] (41X - US0396971071) suspended...…